Pancreatic Cancer Research

ResearcherCornell UniversityActive in the last 2 years

Colin M. Court

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9357-8957; OpenAlex author ID A5030832720. Sources: OpenAlex.

Their work

Papers
10 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
34
Papers, trials and grants by year

2015: 1 paper · 2016: 2 papers · 2017: none · 2018: 3 papers · 2019: none · 2020: none · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper

Papers 10

  1. Reconstitution of human PDAC using primary cells reveals oncogenic transcriptomic features at tumor onset. Co-author DOI 10.1038/s41467-024-45097-2↗
  2. Genomic Biomarkers Associated with Response to Induction Chemotherapy in Patients with Localized Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/1078-0432.ccr-22-3089↗
  3. Association between SMAD4 Mutations and GATA6 Expression in Paired Pancreatic Ductal Adenocarcinoma Tumor Specimens: Data from Two Independent Molecularly-Char… Co-author DOI 10.3390/biomedicines11113058↗
  4. Alterations in Somatic Driver Genes Are Associated with Response to Neoadjuvant FOLFIRINOX in Patients with Localized Pancreatic Ductal Adenocarcinoma. First author DOI 10.1097/xcs.0000000000000212↗
  5. The New American Joint Committee on Cancer TNM Staging System for Pancreatic Cancer-Balancing Usefulness With Prognostication. Co-author DOI 10.1001/jamasurg.2018.3629↗
  6. Pancreatic cancer circulating tumor cells: applications for personalized oncology. Co-author DOI 10.1080/14737159.2018.1511429↗
  7. Circulating Tumor Cells Predict Occult Metastatic Disease and Prognosis in Pancreatic Cancer. Co-author DOI 10.1245/s10434-017-6290-8↗
  8. Reality of Single Circulating Tumor Cell Sequencing for Molecular Diagnostics in Pancreatic Cancer. Co-author DOI 10.1016/j.jmoldx.2016.03.006↗
  9. Circulating tumour cells as a biomarker for diagnosis and staging in pancreatic cancer. First author DOI 10.1038/bjc.2016.121↗
  10. Improving pancreatic cancer diagnosis using circulating tumor cells: prospects for staging and single-cell analysis. Co-author DOI 10.1586/14737159.2015.1091311↗

Closest collaborators

The 25 strongest of 34 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Brett Logan Ecker · 3 shared papers, 2022–2023 · strength 0.46
  2. James S. Tomlinson · 5 shared papers, 2015–2018 · strength 0.35
  3. Michael Ian D'Angelica · 2 shared papers, 2022–2023 · strength 0.30
  4. Eileen Mary O'Reilly · 2 shared papers, 2022–2023 · strength 0.30
  5. Quisette P. Janssen · 2 shared papers, 2022–2023 · strength 0.30
  6. Jeffrey A. Drebin · 2 shared papers, 2022–2023 · strength 0.30
  7. William R. Jarnagin · 2 shared papers, 2022–2023 · strength 0.30
  8. Alice Chia-Chi Wei · 2 shared papers, 2022–2023 · strength 0.30
  9. Jacob S. Ankeny · 4 shared papers, 2015–2018 · strength 0.23
  10. Oscar Joe Hines · 2 shared papers, 2016–2018 · strength 0.22
  11. Zev A. Wainberg · 3 shared papers, 2016–2018 · strength 0.17
  12. Angel A. Dominguez · 1 shared paper, 2024 · strength 0.17
  13. Huamin Wang · 1 shared paper, 2024 · strength 0.17
  14. Yi Xu · 1 shared paper, 2024 · strength 0.17
  15. Pei Wang · 1 shared paper, 2024 · strength 0.17
  16. Aatur Dilip Singhi · 1 shared paper, 2024 · strength 0.17
  17. Martín E. Fernández-Zapico · 1 shared paper, 2024 · strength 0.17
  18. Mariam F. Eskander · 1 shared paper, 2023 · strength 0.17
  19. Subhajyoti De · 1 shared paper, 2023 · strength 0.17
  20. H. Richard Alexander · 1 shared paper, 2023 · strength 0.17
  21. Joshua D. Greendyk · 1 shared paper, 2023 · strength 0.17
  22. Vinod P. Balachandran · 1 shared paper, 2023 · strength 0.14
  23. Anna M. Varghese · 1 shared paper, 2023 · strength 0.14
  24. Kevin C. Soares · 1 shared paper, 2023 · strength 0.14
  25. T. Peter Kingham · 1 shared paper, 2023 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.